European Financial Markets Reap Gains Sparked by Hopes of Potential COVID-19 Vaccine
Europe's benchmark indices were higher due to rising optimism over US drugmaker Pfizer's potential COVID-19 vaccineActualités similaires
Articles similaires à European Financial Markets Reap Gains Sparked by Hopes of Potential COVID-19 Vaccine
Johnson & Johnson Delays European Rollout of COVID-19 Vaccine / /
U.S. pharmaceutical giant cites links of vaccine to rare but potentially deadly blood clot for reason to delay European rolloutActualités similaires
Biden: 90% of US Adults Will Be Eligible for COVID Vaccine by April 19
Meanwhile, CDC director expresses fear of impending doom' from coronavirus resurgenceBritain Grants Emergency Approval of New COVID-19 Vaccine/Developed by U.S.-Based Pfizer and Germany's BioNTech
'Historic moment' makes Britain first Western nation preparing to begin mass inoculations against novel coronavirusActualités similaires
Asian Markets Mostly Higher as Euphoria Over Potential COVID-19 Vaccine Cools//
In futures trading, all three major US indices are trending negativelyActualités similaires
Asian Markets Mostly Higher as Optimism/Grows Over Potential New COVID-19 Vaccine
US indices are mixed in futures trading, with the Dow and the S&P 500 trading negatively, while the Nasdaq is slightly higherActualités similaires
Dow Closes at Record on News of Second Potential COVID-19 Vaccine
Investors cheered by Moderna's announcement of 95% effectiveness rate of experimental vaccineActualités similaires
European Markets Soar on News of Second Potential COVID-19 Vaccine
Investors buoyed by encouraging economic data from Japan and ChinaActualités similaires
European Financial Markets Reap Gains Sparked by Hopes of Potential COVID-19 Vaccine
Europe's benchmark indices were higher due to rising optimism over US drugmaker Pfizer's potential COVID-19 vaccineActualités similaires
Australia Reaches Deal to Secure Millions of Doses of Potential COVID-19 Vaccine//
Canberra makes agreement with Britain's AstraZeneca for 25 million doses of vaccine developed by University of OxfordUS Makes Deal with Biotech Company for 100 Million Doses of Potential COVID-19 Vaccine
Trump's announcement comes hours after Russia announced formal approval of a coronavirus vaccineGlobal Markets Enjoy Boost on Promising News of COVID-19 Vaccine
All three U.S. indexes were trending positively in futures tradingActualités similaires
First Human Trial of Potential COVID-19 Vaccine Underway in Australia
Year-end target for potential vaccine as Australia begins first southern hemisphere's first COVID-19 drug trialActualités similaires
US Secures 300 Million Doses of Potential AstraZeneca COVID-19 Vaccine
After President Donald Trump demanded a vaccine, the US Department of Health and Human Services agreed to provide up to $1.2 billion to accelerate ...Actualités similaires
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
